Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 222

1.

Drug discovery and development using chemical genomics.

Sehgal A.

Curr Opin Drug Discov Devel. 2002 Jul;5(4):526-31. Review.

PMID:
12197310
[PubMed - indexed for MEDLINE]
2.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
[PubMed - indexed for MEDLINE]
3.

Anticancer drug discovery using chemical genomics.

Sehgal A.

Curr Med Chem. 2003 May;10(9):749-55. Review.

PMID:
12678778
[PubMed - indexed for MEDLINE]
4.

Chemical genomics: bridging the gap between the proteome and therapeutics.

Falb D, Jindal S.

Curr Opin Drug Discov Devel. 2002 Jul;5(4):532-9. Review.

PMID:
12197311
[PubMed - indexed for MEDLINE]
5.

Computational chemogenomics approaches to systematic knowledge-based drug discovery.

Mestres J.

Curr Opin Drug Discov Devel. 2004 May;7(3):304-13. Review.

PMID:
15216933
[PubMed - indexed for MEDLINE]
6.

Emerging trends in high-throughput screening.

Entzeroth M.

Curr Opin Pharmacol. 2003 Oct;3(5):522-9. Review.

PMID:
14559099
[PubMed - indexed for MEDLINE]
7.

Chemogenomics: drug discovery's panacea?

Jacoby E.

Mol Biosyst. 2006 May;2(5):218-20. Epub 2006 Mar 30. Review.

PMID:
16880939
[PubMed - indexed for MEDLINE]
8.

Chemical genomics versus orthodox drug development.

Szymkowski DE.

Drug Discov Today. 2003 Feb 15;8(4):157-9. No abstract available.

PMID:
12581708
[PubMed - indexed for MEDLINE]
9.

Chemical genomics: a systematic approach in biological research and drug discovery.

Zheng XF, Chan TF.

Curr Issues Mol Biol. 2002 Apr;4(2):33-43. Review.

PMID:
11931568
[PubMed - indexed for MEDLINE]
Free Article
10.

Beyond the genome--SMi Conference 27-28 January 2003, London, UK.

Swinton J, Sheridan JM, Henning SW.

IDrugs. 2003 Mar;6(3):203-6.

PMID:
12838986
[PubMed - indexed for MEDLINE]
11.

Pharmaceutical education in the wake of genomic technologies for drug development and personalized medicine.

Vizirianakis IS.

Eur J Pharm Sci. 2002 Apr;15(3):243-50. Review.

PMID:
11923056
[PubMed - indexed for MEDLINE]
12.

Natural products in drug discovery: present status and perspectives.

Molinari G.

Adv Exp Med Biol. 2009;655:13-27. doi: 10.1007/978-1-4419-1132-2_2. Review.

PMID:
20047031
[PubMed - indexed for MEDLINE]
13.
14.

Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.

Langer T, Krovat EM.

Curr Opin Drug Discov Devel. 2003 May;6(3):370-6. Review.

PMID:
12833670
[PubMed - indexed for MEDLINE]
15.

Chemical genomics as an emerging paradigm for postgenomic drug discovery.

Salemme FR.

Pharmacogenomics. 2003 May;4(3):257-67. Review.

PMID:
12718717
[PubMed - indexed for MEDLINE]
16.

Progress in functional genomics approaches to antifungal drug target discovery.

De Backer MD, Van Dijck P.

Trends Microbiol. 2003 Oct;11(10):470-8. Review.

PMID:
14557030
[PubMed - indexed for MEDLINE]
17.

Target validation and drug discovery using genomic and protein-protein interaction technologies.

Pillutla RC, Fisher PB, Blume AJ, Goldstein NI.

Expert Opin Ther Targets. 2002 Aug;6(4):517-31. Review.

PMID:
12223066
[PubMed - indexed for MEDLINE]
18.

Affinity-based screening techniques for enhancing lead discovery.

Comess KM, Schurdak ME.

Curr Opin Drug Discov Devel. 2004 Jul;7(4):411-6. Review.

PMID:
15338950
[PubMed - indexed for MEDLINE]
19.

Genetics and genomics in neuropsychopharmacology: the impact on drug discovery and development.

Hurko O.

Eur Neuropsychopharmacol. 2001 Dec;11(6):491-9. Review.

PMID:
11704426
[PubMed - indexed for MEDLINE]
20.

Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases.

Cho CH, Nuttall ME.

Expert Opin Ther Targets. 2002 Dec;6(6):679-89. Review.

PMID:
12472380
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk